Status:
COMPLETED
A Novel Method to Determine HIV Incidence Among Youth
Lead Sponsor:
University of North Carolina, Chapel Hill
Conditions:
HIV Infection
Eligibility:
All Genders
12-24 years
Brief Summary
Identifying young people with early HIV-1 infection is important for increasing linkage to care, for behavioral counseling, and for enrolling individuals into programs that can provide effective inter...
Detailed Description
HIV infection incidence estimates are important, not only for determining specific populations where community HIV education sessions can have the most benefit or where changes in infection patterns a...
Eligibility Criteria
Inclusion
- Age 12 through 24 years
- HIV infection determined by routine HIV testing strategies
- Ability to give informed consent or assent with parental permission, where required
Exclusion
- Visibly distraught or emotionally unstable
- Intoxicated or under the influence of psychoactive agents
- First disclosure of sexual, physical, or emotional abuse
- Clinically presents as acutely ill
Key Trial Info
Start Date :
February 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
440 Patients enrolled
Trial Details
Trial ID
NCT00103883
Start Date
February 1 2003
End Date
March 1 2007
Last Update
March 1 2017
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Los Angeles
Los Angeles, California, United States, 90027
2
University of California at San Diego
San Diego, California, United States, 92103
3
University of California at San Francisco
San Francisco, California, United States, 94118
4
Children's National Medical Center
Washington D.C., District of Columbia, United States, 20010